Page last updated: 2024-10-28

phenelzine and Glucosephosphate Dehydrogenase Deficiency

phenelzine has been researched along with Glucosephosphate Dehydrogenase Deficiency in 2 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Glucosephosphate Dehydrogenase Deficiency: A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
EVANS, DA1
Cohen, BM1
Zubenko, GS1

Other Studies

2 other studies available for phenelzine and Glucosephosphate Dehydrogenase Deficiency

ArticleYear
CONJOINT CLINIC ON DRUGS AND GENES.
    Journal of chronic diseases, 1965, Volume: 18

    Topics: Acetates; Aminosalicylic Acid; Aminosalicylic Acids; Coenzyme A; Diabetes Mellitus; Genetics, Medica

1965
Relevance of genetic variability to clinical psychopharmacology.
    Psychopharmacology bulletin, 1985, Volume: 21, Issue:3

    Topics: Acetylation; Acetyltransferases; Alcohol Oxidoreductases; Aldehyde Oxidoreductases; Antidepressive A

1985